 | • レポートコード：MRC2303J0115 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、257ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、世界の血糖モニタリング市場規模が2021年に8,192.12百万ドル、2022年には8,754.91百万ドルに到達し、今後CAGR 7.12％で成長して2027年までに12,380.55百万ドルまで拡大すると予測しています。当調査資料では、血糖モニタリングの世界市場について調査・分析を行い、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別（連続血糖モニター、セルフ/ワンタイムモニター）分析、検査技術別（電極式血糖モニター、光電式血糖モニター）分析、用途別（妊娠糖尿病、1型糖尿病、2型糖尿病）分析、エンドユーザー別（在宅医療、病院＆クリニック）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目をまとめております。なお、当書に掲載されている企業情報には、Abbott Laboratories、ACON Laboratories、ARKRAY, Inc.、Ascensia Diabetes Care、B. Braun Melsungen AG、Dexcom, Inc.、F. Hoffmann-La Roche Ltd.、Glysens Incorporated、Insulet Corporation、LifeScan IP Holding, LLC.、Medtronic PLC、Nipro Europe Group Companiesなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の血糖モニタリング市場規模：製品別 - 連続血糖モニターの市場規模 - セルフ/ワンタイムモニターの市場規模 ・世界の血糖モニタリング市場規模：検査技術別 - 電極式血糖モニターの市場規模 - 光電式血糖モニターの市場規模 ・世界の血糖モニタリング市場規模：用途別 - 妊娠糖尿病における市場規模 - 1型糖尿病における市場規模 - 2型糖尿病における市場規模 ・世界の血糖モニタリング市場規模：エンドユーザー別 - 在宅医療における市場規模 - 病院＆クリニックにおける市場規模 ・世界の血糖モニタリング市場規模：地域別 - 南北アメリカの血糖モニタリング市場規模 アメリカの血糖モニタリング市場規模 カナダの血糖モニタリング市場規模 ブラジルの血糖モニタリング市場規模 ... - アジア太平洋の血糖モニタリング市場規模 日本の血糖モニタリング市場規模 中国の血糖モニタリング市場規模 インドの血糖モニタリング市場規模 韓国の血糖モニタリング市場規模 台湾の血糖モニタリング市場規模 ... - ヨーロッパ/中東/アフリカの血糖モニタリング市場規模 イギリスの血糖モニタリング市場規模 ドイツの血糖モニタリング市場規模 フランスの血糖モニタリング市場規模 ロシアの血糖モニタリング市場規模 ... - その他地域の血糖モニタリング市場規模 ・競争状況 ・企業情報 |
The Global Blood Glucose Monitoring Market size was estimated at USD 8,192.12 million in 2021 and expected to reach USD 8,754.91 million in 2022, and is projected to grow at a CAGR 7.12% to reach USD 12,380.55 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Blood Glucose Monitoring to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Continuous Blood Glucose Monitors and Self / One Time Monitors. The Continuous Blood Glucose Monitors is further studied across Insulin Pumps, Sensors, and Transmitter & Receiver. The Self / One Time Monitors is further studied across Blood Glucose Meter, Lancets, and Testing Strips.
Based on Testing Technology, the market was studied across Electrode Type Blood Glucose Monitor and Photoelectric Blood Glucose Monitor.
Based on Application, the market was studied across Gestational Diabetes, Type 1 Diabetes, and Type 2 Diabetes.
Based on End-user, the market was studied across Home Care and Hospital & Clinics.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Blood Glucose Monitoring market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Blood Glucose Monitoring Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Blood Glucose Monitoring Market, including Abbott Laboratories, ACON Laboratories, ARKRAY, Inc., Ascensia Diabetes Care, B. Braun Melsungen AG, Dexcom, Inc., F. Hoffmann-La Roche Ltd., Glysens Incorporated, Insulet Corporation, LifeScan IP Holding, LLC., Medtronic PLC, Nipro Europe Group Companies, Nova Biomedical, Novo Nordisk, PHC Holding Corporation, Prodigy Diabetes Care, Sanofi, Senseonics, Terumo Corporation, Trividia Health, Inc. (Sinocare Inc.), and Ypsomed Holdings.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Blood Glucose Monitoring Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Blood Glucose Monitoring Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Blood Glucose Monitoring Market?
4. What is the competitive strategic window for opportunities in the Global Blood Glucose Monitoring Market?
5. What are the technology trends and regulatory frameworks in the Global Blood Glucose Monitoring Market?
6. What is the market share of the leading vendors in the Global Blood Glucose Monitoring Market?
7. What modes and strategic moves are considered suitable for entering the Global Blood Glucose Monitoring Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of diabetic patients across the globe
5.1.1.2. Significant awareness about diabtetic preventive care among consumers
5.1.1.3. Rising favorable reimbursement policies
5.1.2. Restraints
5.1.2.1. Issues pertaining to high cost of blood glucose monitors
5.1.3. Opportunities
5.1.3.1. Emerging innovations in self-monitoring blood glucose devices
5.1.3.2. Introduction of non-invasive blood glucose monitors
5.1.4. Challenges
5.1.4.1. Concern associated with product recalls due to safety and efficacy issues
5.2. Cumulative Impact of COVID-19
6. Blood Glucose Monitoring Market, by Product
6.1. Introduction
6.2. Continuous Blood Glucose Monitors
6.3.1. Insulin Pumps
6.3.2. Sensors
6.3.3. Transmitter & Receiver
6.3. Self / One Time Monitors
6.4.1. Blood Glucose Meter
6.4.2. Lancets
6.4.3. Testing Strips
7. Blood Glucose Monitoring Market, by Testing Technology
7.1. Introduction
7.2. Electrode Type Blood Glucose Monitor
7.3. Photoelectric Blood Glucose Monitor
8. Blood Glucose Monitoring Market, by Application
8.1. Introduction
8.2. Gestational Diabetes
8.3. Type 1 Diabetes
8.4. Type 2 Diabetes
9. Blood Glucose Monitoring Market, by End-user
9.1. Introduction
9.2. Home Care
9.3. Hospital & Clinics
10. Americas Blood Glucose Monitoring Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Blood Glucose Monitoring Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Blood Glucose Monitoring Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Abbott Laboratories
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. ACON Laboratories
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. ARKRAY, Inc.
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Ascensia Diabetes Care
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. B. Braun Melsungen AG
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Dexcom, Inc.
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. F. Hoffmann-La Roche Ltd.
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Glysens Incorporated
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Insulet Corporation
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. LifeScan IP Holding, LLC.
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Medtronic PLC
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Nipro Europe Group Companies
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Nova Biomedical
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Novo Nordisk
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. PHC Holding Corporation
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Prodigy Diabetes Care
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Sanofi
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Senseonics
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Terumo Corporation
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Trividia Health, Inc. (Sinocare Inc.)
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
14.21. Ypsomed Holdings
14.21.1. Business Overview
14.21.2. Key Executives
14.21.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing